Aegerion Pharmaceuticals to Announce Fourth Quarter 2012 Financial Results on
Wednesday, March 6
CAMBRIDGE, Mass., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals,
Inc.(Nasdaq:AEGR), a biopharmaceutical company dedicated to the development
and commercialization of innovative, life-altering therapies for patients with
debilitating, often fatal rare diseases, announced that the Company will host
a conference call and live audio webcast at 8:30 a.m. EST on Wednesday, March
6, 2013, to provide a business update and discuss its fourth quarter and year
end 2012 financial and operational results.
To listen to the live webcast of the call, please visit the "Investors"
section of the Company's website at www.aegerion.com. Individuals may also
participate in the call via telephone by dialing (866) 516-3002 or (760)
298-5082. Interested parties unable to join the live call may access an
archived version of the webcast on Aegerion's website for 14 days following
About Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the
development and commercialization of innovative, life-altering therapies for
patients with debilitating, often fatal, rare diseases.For more information
about the company, please visit www.aegerion.com.
The Aegerion Pharmaceuticals, Inc. logo is available at
CONTACT: Aegerion Pharmaceuticals, Inc.
Amanda Murphy, Manager, IR
Aegerion Pharmaceuticals, Inc. Logo
Press spacebar to pause and continue. Press esc to stop.